Abingdon Health (LON:ABDX) Releases Quarterly Earnings Results

Abingdon Health (LON:ABDX) released its quarterly earnings results on Monday. The company reported GBX (0.53) (($0.01)) EPS for the quarter, Digital Look Earnings reports. Abingdon Health had a negative return on equity of 62.56% and a negative net margin of 20.72%.

Abingdon Health Stock Down 0.8 %

Shares of LON:ABDX opened at GBX 6.45 ($0.08) on Wednesday. Abingdon Health has a 12 month low of GBX 6 ($0.08) and a 12 month high of GBX 11.75 ($0.15). The firm has a market cap of £12.49 million, a P/E ratio of -15.68 and a beta of 0.13. The company has a quick ratio of 1.96, a current ratio of 1.95 and a debt-to-equity ratio of 46.64. The company’s 50-day moving average price is GBX 7.46 and its two-hundred day moving average price is GBX 7.96.

Abingdon Health Company Profile

Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.